HGISA: Seek and ye shall find [5]

Lancet

Volumn 364, Issue 9433, 2004, Pages 500-501

  Howe, Robin A ^a   Walsh, Timothy R ^a,b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GLYCOPEPTIDE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; AREA UNDER THE CURVE; BACTEREMIA; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GENE CASSETTE; GEOGRAPHIC DISTRIBUTION; HETEROGENEOUS INTERMEDIATE GLYCOPEPTIDE RESISTANT STAPHYLOCOCCUS AUREUS; HUMAN; JAPAN; LENGTH OF STAY; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPIC VARIATION; POPULATION GENETICS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; STRAIN IDENTIFICATION; TREATMENT OUTCOME;

EID: 4043154818     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16803-7     Document Type: Letter

References (5)

1. Arakawa Y, Ike Y, Nagasawa M. Where has vancomycin-heterogeneously resistant Staphylococcus aureus gone? Lancet. 363:2004;1401
2. Ike Y, Arakawa Y, Ma X, et al. Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals. J Clin Microbiol. 39:2001;4445-4451
3. Hiramatsu K, Aritaka N, Hanatzi H, et al. Dissemination in Japanes hospitals of strains of Staphylococcus arueus heterogeneously resistant to vancomycin. Lancet. 350:1997;1670-1673
4. Walsh TR, Howe RA. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Ann Rev Microbiol. 56:2002;657-675
5. Charles PGB, Ward PB, Johnson PDR, Howden BP, Grayson ML. Clinical features associated with bacteraemia due to heterogeneous vancomycin- intermediate Staphylococcus aureus. Clin Infect Dis. 38:2004;448-451